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Abstract
Understanding treatment heterogeneity is essential to the development of precision medicine,
which seeks to tailor medical treatments to subgroups of patients with similar characteristics. One
of the challenges of achieving this goal is that we usually do not have a priori knowledge of the
grouping information of patients with respect to treatment effect. To address this problem, we
consider a heterogeneous regression model which allows the coefficients for treatment variables to
be subject-dependent with unknown grouping information. We develop a concave fusion penalized
method for estimating the grouping structure and the subgroup-specific treatment effects, and
derive an alternating direction method of multipliers algorithm for its implementation. We also
study the theoretical properties of the proposed method and show that under suitable conditions
there exists a local minimizer that equals the oracle least squares estimator based on a priori
knowledge of the true grouping information with high probability. This provides theoretical support
for making statistical inference about the subgroup-specific treatment effects using the proposed
method. The proposed method is illustrated in simulation studies and illustrated with real data
from an AIDS Clinical Trials Group Study.
Key Words: Fusiongram; Oracle property; Penalized least squares; Subgroup analysis; Treatment
heterogeneity
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1 Introduction
Treatment effects are often heterogeneous, that is, the same treatment can have different effects
on different patients (Sorensen, 1996; Kravitz et al., 2004). For instance, molecularly targeted
cancer drugs are only effective for patients with tumors expressing targets (Simon, 2010), and
the relative efficacy of antiretroviral drugs for treating human immunodeficiency virus infection
sometimes depends on baseline viral load and CD4 count (Zhang et al., 2014). Understanding the
heterogeneity of treatment effects (HTE) is critical to the eventual success of precision medicine,
which seeks to tailor medical treatments to individual patients.
Possible HTE is usually assessed in a subgroup analysis (Gail and Simon, 1985; Russek-Cohen and Simon,
1998; Kravitz et al., 2004; Rothwell, 2005; Lagakos, 2006) or, more generally, a regression analysis
relating the outcome of interest to treatment and a collection of baseline covariates (?). Such a re-
gression model can incorporate HTE as interactions between treatment and baseline covariates, and
can be used to estimate covariate-specific treatment effects indirectly. Alternatively, a covariate-
specific treatment effect model can be specified and estimated directly without relying on a regres-
sion model for the outcome (Tian et al., 2014; Zhang et al., 2017). There is also a growing literature
on HTE estimation using machine learning methods (e.g. Su et al., 2011; Imai and Ratkovic, 2013;
Su et al., 2018). All of these methods are based on observed baseline covariates; they do not address
possible HTE due to unmeasured covariates.
The collection of observed baseline covariates is often limited, and thus may be insufficient for
characterizing the true HTE across individual patients. The true HTE structure is not empirically
identifiable unless all effect modifiers are measured, but can be explored under appropriate assump-
tions. Zhang et al. (2013, 2014) use random effect models to conduct sensitivity analyses concerning
the joint distribution of two potential outcomes (for two different treatments). Shen and He (2015)
propose a two-group logistic-normal mixture model for the true HTE and develop a model-based
procedure for testing the equivalence of the two groups. The model of Shen and He (2015) includes
a normality assumption for the outcome and a logistic regression model relating the latent group
membership to a collection of observed covariates.
In this article, we propose a general latent class model for exploring the true HTE. Different
from the aforementioned existing models, our model deals with an unspecified number of latent
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groups, without assuming normality for the outcome or a particular relationship between the latent
group membership and the observed covariates. In our model, we assume that the treatment coeffi-
cients are subject-specific and belong to different groups with unknown grouping information. The
subgroups, therefore, can be driven by observed covariates, unobserved covariates or an arbitrary
combination of both types of covariates. We recover the latent subgroups and estimate the model
using concave fusion penalization, an unsupervised machine learning method, that applies a concave
penalty, such as the smoothly clipped absolute deviations penalty (SCAD, Fan and Li, 2001) or the
minimax concave penalty (MCP, Zhang, 2010), to pairwise differences of coefficients for treatment
effects. The fusion penalized approach has been proposed for clustering analysis of grouping data
objects (Chi and Lange, 2015) and grouping means of clinical outcomes with random errors (?), but
not for exploring HTE. ? briefly mentioned potential applications of the fusion penalized approach
to the estimation of subject-specific coefficient models without providing theoretical justifications
and numerical studies.
We consider the present paper as the first work which applies the fusion learning approach to
the investigation of HTE through subject-specific treatment coefficients and provides a theoretical
analysis of the resulting estimator for the proposed general latent class model with subject-specific
treatment effects. The consistency and asymptotic distributional properties of the estimators follow
from the fact that, under appropriate conditions, the oracle least squares estimator based on a priori
knowledge of the true group membership is a local minimizer of the objective function with high
probability. Moreover, we derive the conditions on the number of subgroups and the number of
covariates compared with the sample size as well as the lower bound of the minimum difference of
coefficient values between the subgroups in order to identify the true subgroups of treatment effects.
Computationally, we apply an alternating direction method of multipliers (ADMM) algorithm
(Boyd et al., 2011) for implementing the proposed approach. This algorithm has been used widely
in convex optimization problems. We derive the convergence properties of the ADMM in the present
setting. Another contribution is that using the proposed fusion penalized estimator, we further
propose a bootstrapping procedure to test homogeneity of the treatment effects for confirmatory
analysis.
The rest of this article is organized as follows. Section 2 introduces the proposed latent class
model. Section 3 describes the concave fusion penalization method for model estimation. In
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Section 4 we establish the theoretical properties of the proposed estimator. Section 5 introduces
a bootstrapping procedure for testing homogeneity. In Section 6 we evaluate the finite-sample
properties of the proposed method via simulation studies, and apply the method to AIDS Clinical
Trials Group Study 175. Concluding remarks are given in Section 7. The computational algorithm
and the technical proofs are provided in the Appendix.
2 Model
Suppose the data consist of (yi,zi,xi), i = 1, . . . , n, where yi is an outcome variable, zi a q-
vector of patient characteristics related to the outcome, and xi a p-vector of treatment or exposure
characteristics. The vector xi may include discrete components (e.g., indicators of treatment groups
or exposure status) and/or continuous components (e.g., dose of drug or radiation). Our goal is to
understand how the causal effect of xi may vary across individual subjects. Let yi(x) denote the
potential outcome for the ith subject under treatment x (Rubin, 1974). We assume that treatment
assignment is strongly ignorable (Rosenbaum, 1983) in the sense that
xi ⊥ yi(x)|zi, (2.1)
where ⊥ denotes independence and x may be any treatment that could conceivably be given to the
ith subject. From this assumption it follows that
E{yi(x)|zi} = E{yi(x)|zi,xi = x} = E{yi|zi,xi = x},
which is empirically identified for any possibly treatment x for the ith subject. Assumption (2.1)
is trivially true in a randomized clinical trial where xi is independent of all baseline variables; in
this case, adjustment for zi is not strictly necessary but may improve efficiency.
Suppose the data generation mechanism can be described by the following linear regression
model:
yi = z
T
i η + x
T
i βi + εi, i = 1, . . . , n, (2.2)
where η and βi are unknown regression coefficients and the εi’s are i.i.d. random errors with
E(εi) = 0 and Var(εi) = σ
2. We assume that the first entry in each xi is 1 so the intercept is
included in βi. Under this model and the strongly ignorable treatment assignment assumption,
the subject-specific regression coefficient βi represents the causal effect of xi on the i
th subject,
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and the distribution of βi across i represents the true HTE. With more unknown parameters than
observations, model (2.2) is not estimable without additional assumptions.
A simple way to constrain model (2.2) and achieve identification is to assume that the βi are
all equal. This leads to the following model:
yi = z
T
i η + x
T
i β + εi, i = 1, . . . , n, (2.3)
which is commonly used in practice. Model (2.3) is quite restrictive as it rules out any HTE with
respect to observed and unobserved covariates. The model can be expanded by including interaction
terms between some or all components of zi and xi, thereby allowing βi to be a specified function
of zi. The expanded model can accommodate a particular form of observed HTE, but it does not
account for any latent HTE. Moreover, even if the HTE is only driven by the observed covariates
zi, it is unclear in what specific form zi causes the HTE. For instance, the common assumption
that βi = β+Γti, where ti is a subset of zi, and β and Γ are coefficients implies a linear interaction
structure which may be too stringent in practice. When many baseline variables are present, there
can be many interaction terms. This increases the chance of false positive results in interaction
tests and may lead to overstated and misleading conclusions (Wang et al., 2007).
Another approach is to treat βi as a subject-specific random vector following a specified con-
ditional distribution given zi. A prominent example in this category is the common linear mixed
model where βi is assumed to follow a normal distribution, independently of zi. Such a model may
have identifiability issues in the present setting, where each subject contributes only one observation.
Another example in this category, which achieves identifiability, is the two-group logistic-normal
mixture model of Shen and He (2015). In the present notation, their model can be expressed as
yi = x
T
i βi + εi, where βi = α1 +α2wi and wi = I(z
T
i γ + ǫ > 0), (2.4)
where ǫ is an error distributed by the standard logistic distribution, so that P (wi = 1|zi) =
exp(zTi γ)/(1+exp(z
T
i γ)). This model assumes that the βi in (2.2) arise from a finite mixture model
with two possible values (α1 and α1 + α2), that εi is normally distributed, and that the latent
group membership is related to observed covariates through a logistic regression model. Under
these assumptions, model (2.4) can be estimated using a standard EM algorithm, and Shen and He
(2015) further develop an EM test for the null hypothesis α2 = 0, which indicates the absence
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of (observed or latent) HTE. This approach, as a model-based way to estimate the true HTE, is
limited by the two-group assumption and the modeling assumptions.
Here we consider a more flexible latent class model and propose a machine learning approach
to recovering the subgroups. We assume that the βi in (2.2) arise from a mixture model with an
unspecified number of groups. Specifically, let G = (G1, . . . ,GK) be a mutually exclusive partition
of {1, . . . , n}. Suppose βi = αk for all i ∈ Gk, where αk is the common value for the βi’s in group
Gk. In other words, we assume that
βi = α1wi1 +α2wi2 + · · ·+αKwiK ,
where αk = (αk1, . . . , αkp)
T, and wik ∈ (0, 1) is the (latent) indicator for the kth group Gk, i.e.,
wik = 1 for i ∈ Gk and wik = 0 otherwise. Substituting this into model (2.2) yields the latent class
model:
yi = z
T
i η + x
T
i (α1wi1 +α2wi2 + · · · +αKwiK) + εi, (2.5)
where the number of subgroups K is unknown and the group indicators wik are unobservable.
Model (2.5) includes the case of no HTE as a special case (i.e., K = 1 and hence wi1 ≡ 1). Of note,
we do not parameterize the distribution of εi, nor do we specify how the wik’s may be related to
zi. Thus, our model is considerably more flexible than the model of Shen and He (2015).
Although the subgroups in model (2.5) are not (fully) ascertainable using observed covariates,
an exploratory analysis based on model (2.5) can provide unique insights into the true HTE and
helpful guidance for future research. For example, if the results indicate that a new treatment
only benefits a small (and unidentified) proportion of the patient population, that finding might
motivate scientists to collect more covariate data (e.g., biomarkers) in future studies and search
for predictors of treatment benefit. Conversely, if there is no indication of clinically important
HTE, that information would support a decision to (re)direct limited resources toward other, more
promising areas of research.
3 Estimation
To identify the subgroups of the heterogeneous treatment effects, we first need to estimate model
(2.5), i.e., we need to estimate the number of subgroups K, the coefficients η and α, and the group
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membership wik for each observation. Estimating model (2.5) is the same as estimation of model
(2.2), since they are the same models with different notations. We propose a concave fusion method
for model estimation described below.
For any vector a, denote its L2 norm by ‖a‖ = (
∑ |ai|2)1/2. Consider the criterion
Qn(η,β) =
1
2
∑n
i=1
(yi − zTi η − xTi βi)2 +
∑
1≤i<j≤n
p(‖βi − βj‖, λ), (3.1)
where β = (βT1 , . . . ,β
T
n )
T, and p(·, λ) is a penalty function with a tuning parameter λ ≥ 0. For a
given λ > 0, let
(η̂(λ), β̂(λ)) = argmin
η∈IRq ,β∈IRnp
Qn(η,β;λ). (3.2)
We use sparsity-inducing penalties (to be discussed later) in (3.1). For a sufficiently large λ,
the penalty shrinks some of ‖βi − βj‖ to zero. We partition the treatment effects into subgroups
according to the unique values of β̂. Specifically, let λ̂ be the value of the tuning parameter
on the path selected based on a data-driven procedure such as the BIC. For simplicity, write
(η̂, β̂) ≡ (η̂(λ̂), β̂(λ̂)). Let {α̂1, . . . , α̂K̂} be the distinct values of β̂, where K̂ is the number of
the distinct values. These are the estimates of subgroup-specific treatment effects. The samples
can then be divided into subgroups accordingly. Denote the set of indices of the kth subgroup by
Ĝk = {i : β̂i = α̂k, 1 ≤ i ≤ n}, 1 ≤ k ≤ K̂. Accordingly, we have ŵik = 1, if i ∈ Ĝk and ŵik = 0,
otherwise.
A popular sparsity-inducing penalty is the L1 or lasso penalty with pγ(t, λ) = λ|t| (Tibshirani,
1996), but this penalty tends to produce too many subgroups (?). Thus, we focus on two concave
penalty functions: the smoothly clipped absolute deviation penalty (SCAD, Fan and Li, 2001) and
the minimax concave penalty (MCP, Zhang, 2010). The SCAD penalty is
pγ(t, λ) = λ
∫ |t|
0
min{1, (γ − x/λ)+/(γ − 1)}dx.
The MCP has the form
pγ(t, λ) = λ
∫ |t|
0
(1− x/(γλ))+dx.
These penalties lead to nearly unbiased estimators of the parameters due to the fact that their
derivatives equal to zero at large (in magnitude) values of the parameter estimates. Moreover, they
are more aggressive in enforcing a sparser solution. Thus, they are better suited for the current
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Figure 1: Solution paths for (β̂21(λ), . . . , β̂2n(λ)) against λ with n = 200 for data from Example 1
in Section 6.
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problem, where the number of subgroups may be expected to be much smaller than the sample
size.
We compute (η̂(λ), β̂(λ)) given in (3.2) for λ in a given interval [λmin, λmax], where λmax is the
value that forces a constant β̂ solution, i.e., β̂j(λmax) = β̂k(λmax), 1 ≤ j < k ≤ n; λmin is a small
positive number. We are particularly interested in the path {β̂(λ) : λ ∈ [λmin, λmax]}. The ADMM
algorithm for computing the solution path on a grid of λ values is described in detail in Section A.1
of the Appendix. We also derive the convergence property of the ADMM algorithm with concave
penalties. The result is given in Proposition A.1 of the Appendix.
Figure 1 illustrates the solution path for the estimates of the treatment coefficients
(β̂21(λ), . . . , β̂2n(λ)) against λ using MCP, SCAD and lasso penalties for simulated data in Example
1 of Section 6, which has two subgroups with ‘treatment effects’ 0 and 2, respectively. The path is
calculated using a “bottom up” approach starting from λmin. It looks similar to the dendrogram
for agglomerative hierarchical clustering. However, unlike the clustering algorithms which form
the clusters based on a direct measure of dissimilarity, the fusion of the coefficients is based on
solving the optimization problems along the solution path. We shall refer to the solution path
{β̂(λ), λ ∈ [λmin, λmax]} as a fusiongram.
In Figure 1, the fusiongrams for SCAD and MCP look similar. They both include a segment
containing nearly unbiased estimates of the treatment effects. When the λ value reaches around
0.6, the estimates of (β21, . . . , β2n) merge into two values that are close to the true values 0 and 2.
When the λ value exceeds 1.0, the estimates shrink to one value. For the lasso, the estimates of
(β21, . . . , β2n) merge to one value quickly at λ = 0.05 due to the overshrinkage of the L1 penalty.
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4 Theoretical properties
In this section, we study the theoretical properties of the proposed estimator. Specifically, we
provide sufficient conditions under which there exists a local minimizer of the objective function
equal to the oracle least squares estimator with a priori knowledge of the true groups with high
probability. We also derive the lower bound of the minimum difference of coefficients between
subgroups in order to be able to estimate the subgroup-specific treatment effects.
4.1 Notation and conditions
Let W˜= {wik} be an n×K matrix with wik = 1 for i ∈ Gk and wik = 0 otherwise. LetW =W˜⊗Ip.
Let MG = {β ∈ IRnp : βi = βj , for any i, j ∈ Gk, 1 ≤ k ≤ K}. For each β ∈ MG , it can be written
as β = Wα, where α = (αT1 , . . . ,α
T
K)
T and αk is a p × 1 vector of the kth subgroup-specific
parameter for k = 1, . . . ,K. Simple calculation shows
WTW = diag(|G1| , . . . , |GK |)⊗Ip,
where |Gk| denotes the number of elements in Gk. Denote the minimum and maximum group sizes
by |Gmin|=min1≤k≤K |Gk| and |Gmax|=max1≤k≤K |Gk|, respectively. For any positive numbers an
and bn, let an ≫ bn denote a−1n bn = o(1). For any vector ζ = (ζ1, . . . , ζs)T ∈ IRs, let ‖ζ‖∞ =
max1≤l≤s |ζl| . For any symmetric matrix As×s, denote its L2 norm by ‖A‖ = maxζ∈Rs,‖ζ‖=1 ‖Aζ‖,
and let λmin(A) and λmax(A) be the smallest and largest eigenvalues of A, respectively. For
any matrix A =(Aij)
s,t
i=1,j=1, denote ‖A‖∞ = max1≤i≤s
∑t
j=1 |Aij |. Let y = (y1, . . . , yn)T, Z =
(z1, . . . ,zn)
T, and X =diag(xT1 , . . . ,x
T
n ). Denote X˜ = XW and U = (Z,XW). Finally, denote
the scaled penalty function by
ρ(t) = λ−1pγ(t, λ).
We make the following basic assumptions.
(C1) The function ρ(t) is symmetric, non-decreasing and concave on [0,∞). It is constant for
t ≥ aλ for some constant a > 0, and ρ(0) = 0. In addition, ρ′(t) exists and is continuous
except for a finite number values of t and ρ′(0+) = 1.
(C2) The noise vector ε = (ε1, . . . , εn)
T has sub-Gaussian tails such that P (|aTε| > ‖a‖x) ≤
2 exp(−c1x2) for any vector a ∈ IRn and x > 0, where 0 < c1 <∞.
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(C3) Assume
∑n
i=1 z
2
il = n for 1 ≤ l ≤ q, and
∑n
i=1 x
2
ij1{i ∈ Gk } = |Gk| for 1 ≤ j ≤ p,
λmin(U
TU) ≥ C1 |Gmin|, supi ‖xi‖ ≤ C2
√
p and supi ‖zi‖ ≤ C3
√
q for some constants 0 <
C1 <∞, 0 < C2 <∞ and 0 < C3 <∞.
Conditions (C1) and (C2) are common assumptions in penalized regression in high-dimensional
settings. The concave penalties such as MCP and SCAD satisfy (C1). In the literature, it is
commonly assumed that the smallest eigenvalue of the transpose of the design matrix multiplied
by the design matrix is bounded by C1n, which may not hold for U
TU. By some calculation and
X˜ = XW, we have
X˜TX˜ = diag(
∑
i∈Gk
xix
T
i , k = 1, . . . ,K).
By assuming that λmin(
∑
i∈Gk
xix
T
i )≥c |Gk| for some constant 0 < c < ∞, we have λmin(X˜TX˜) ≥
c |Gmin|. If ZTX˜ = 0 and λmin(ZTZ) ≥Cn, we have
λmin(U
TU) = min{λmin(ZTZ),λmin(X˜TX˜)} ≥ min(c |Gmin| , Cn),
and |Gmin| ≤ n/K. Therefore, we let the smallest eigenvalue in Condition (C3) be bounded below
by C1 |Gmin|.
4.2 Heterogeneous model
In this section, we study the theoretical properties of the proposed estimator under the heteroge-
neous model in which there are at least two subgroups, that is, K ≥ 2. If the underlying groups
G1, . . . ,GK were known, the oracle estimator of (η,β) would be
(η̂or, βˆ
or
) = argmin
η∈IRq,β∈MG
1
2
‖y − Zη −Xβ‖2. (4.1)
Since β = W˜α, the oracle estimators for the common coefficient α and the coefficients η are
(η̂or, α̂or) = argmin
η∈ IRq ,α∈ IRKp
1
2
‖y − Zη − X˜α‖2 = (UTU)−1UTy.
Let α0k be the true common coefficient vector for group Gk, k = 1, . . . ,K and α0 = ((α0k)T, k =
1, . . . ,K)T. Of course, oracle estimators are not real estimators; they are theoretical constructions
useful for stating the properties of the proposed estimators.
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Theorem 1 Suppose |Gmin| ≫
√
(q +Kp)n log n. Then under Conditions (C1)-(C3), we have
with probability at least 1− 2(Kp+ q)n−1,
∥∥((η̂or − η0)T, (α̂or −α0)T)T∥∥ ≤ φn, (4.2)
and ∥∥∥β̂or − β0∥∥∥ ≤√|Gmax|φn, sup
i
∥∥∥β̂ori − β0i∥∥∥ ≤ φn,
where
φn = c
−1/2
1 C
−1
1
√
q +Kp |Gmin|−1
√
n log n. (4.3)
Moreover, for any vector an ∈ IRq+Kp with ||an|| = 1, we have as n→∞,
σn(an)
−1aTn ((η̂
or − η0)T, (α̂or −α0)T)T →D N(0, 1), (4.4)
where
σn(an) = σ
[
aTn (U
TU)−1an
]1/2
. (4.5)
Remark 1 Since |Gmin| ≤ n/K, by the condition |Gmin| ≫
√
(q +Kp)n log n, then q, K and p
must satisfy K
√
q +Kp = o{√n(log n)−1}.
Remark 2 By letting |Gmin| = δn/K for some constant 0 < δ ≤ 1, the bound (4.2) is φn =
c
−1/2
1 C
−1
1 δ
−1K
√
q +Kp
√
log n/n. Moreover, if q, K and p are fixed quantities, then φn = C
∗
√
log n/n
for some constant 0 < C∗ <∞.
Let
bn = min
i∈Gk,j∈Gk′ ,k 6=k
′
‖β0i − β0j‖ = min
k 6=k′
‖α0k −α0k′‖
be the minimal difference of the common values between two groups.
Theorem 2 Suppose the conditions in Theorem 1 hold. If bn > aλ and λ≫ φn, for some constant
a > 0, where φn is given in (4.3), then there exists a local minimizer (η̂(λ), β̂(λ)) of the objective
function Qn(η,β;λ) given in (3.1) satisfying
P
(
(η̂(λ), β̂(λ)) = (η̂or, β̂
or
)
)
→ 1.
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Remark 3 Theorem 2 shows that the oracle estimator (η̂or, β̂
or
) is a local minimizer of the objec-
tive function with a high probability, and thus the true groups can be recovered with the estimated
common value for group k given as α̂k(λ) = β̂
or
i for i ∈ Gk. This result holds given that bn ≫ φn.
As discussed in Remark 2, when K, p and q are finite and fixed numbers and |Gmin| = δn/K for
some constant 0 < δ ≤ 1, bn ≫ C∗
√
log n/n for some constant 0 < C∗ <∞.
Let α̂(λ) = (α̂1(λ)
T, . . . , α̂K(λ)
T)T be the estimated treatment effects such that α̂k(λ) = β̂i(λ)
for i ∈ Gk, where k = 1, . . . ,K, and β̂(λ) = {β̂i(λ)T, 1 ≤ i ≤ n}T is the local minimizer given in
Theorem 2. Based on the results in Theorems 1 and 2, we obtain the asymptotic distribution of
(η̂(λ)T, α̂(λ)T)T given in the following corollary.
Corollary 1 Under the conditions in Theorem 2, we have for any an ∈ IRq+Kp with ||an|| = 1, as
n→∞,
σn(an)
−1aTn ((η̂(λ)− η0)T, (α̂(λ)−α0)T)T →D N(0, 1),
with σn(an) given in (4.5). As a result, we have for any vectors an1 ∈ IRq with ||an1|| = 1 and
an2 ∈ IRKp ||an2|| = 1, as n→∞,
σ−1n1 (an1)a
T
n1(η̂(λ)− η0)→D N(0, 1) and σ−1n2 (an2)aTn2(α̂(λ)−α0)→D N(0, 1),
where
σn1(an1) = σ
[
aTn1[Z
TZ− ZTX˜(X˜TX˜)−1X˜TZ]−1an1
]1/2
,
σn2(an2) = σ
[
aTn2[X˜
TX˜− X˜TZ(ZTZ)−1ZTX˜]−1an2
]1/2
.
Remark 4 From the oracle property in Theorem 2, we have that P (K̂ = K) → 1, K̂ is the
estimated number of subgroups. Moreover, since β̂
or
= W˜αor and β̂(λ) =
̂˜
Wα̂(λ), then P (
̂˜
W =
W˜) → 1, where ̂˜W = {ŵik} with ŵik = 1 for i ∈ Ĝk and wik = 0 otherwise. Hence, the subgroup
memberships can be recovered with a high probability.
Remark 5 The asymptotic distribution of the penalized estimators provides a theoretical justifica-
tion for further conducting statistical inference about heterogeneity. By the results in Corollary 1,
for given an1 ∈ IRq and an2 ∈ IRKp, 100(1 − α)% confidence intervals for aTn1η0 and aTn2α0 are
given by
aTn1η̂(λ)± zα/2σ̂n1(an1) and aTn2α̂(λ)± zα/2σ̂n2(an2),
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respectively, where zα/2 is the (1 − α/2)100 percentile of the standard normal, and σ̂n1(an1) and
σ̂n2(an2) are estimates of σn1(an1) and σn2(an2) with σ
2 estimated by
σ̂2 = (n− q − K̂p)−1
∑n
i=1
(yi − zTi η̂ − xTi β̂i)2.
4.3 Homogeneous model
When the true model is the homogeneous model given as yi = z
T
i η + x
T
i α + εi, i = 1, . . . , n, we
have β1 = · · · = βn = α and K = 1. The penalized estimator (η̂(λ), β̂(λ)) of (η,β), where
β = (βT1 , . . . ,β
T
n )
T, also has the oracle property given as follows. We define the oracle estimator
for (η,α) as
(η̂or, α̂or) = argmin
η∈ IRq ,α∈ IRp
1
2
‖y − Zη − xα‖2
= (U∗TU∗)−1U∗Ty,
where x =(x1, . . . ,xn)
T and U∗ = (Z,x). Let β̂
or
= (β̂
orT
1 , . . . , β̂
orT
n )
T, where β̂
or
i = α̂
or for all i.
Let η0 and α0 be the true coefficient vectors. We introduce the following condition.
(C3∗) Assume
∑n
i=1 z
2
il = n for 1 ≤ l ≤ q, and
∑n
i=1 x
2
ij = n for 1 ≤ j ≤ p, λmin(U∗TU∗) ≥ C1n,
supi ‖xi‖ ≤ C2√p and supi ‖zi‖ ≤ C3√q for some constants 0 < C1 < ∞, 0 < C2 < ∞ and
0 < C3 <∞.
Theorem 3 Suppose Conditions (C1), (C2) and (C3∗) hold. If p = o(n(log n)−1) and q =
o(n(log n)−1), the oracle estimator has the property that with probability at least 1− 2(p + q)n−1,
∥∥((η̂or − η0)T, (α̂or −α0)T)T∥∥ ≤ φn,
sup
i
∥∥∥β̂ori − β0i ∥∥∥ ≤ φn, (4.6)
where
φn = c
−1/2
1 C
−1
1
√
q + p
√
n−1 log n,
in which c1 and C1 are given in Conditions (C2) and (C3
∗), respectively, and for any vector
an ∈ IRq+p with ||an|| = 1, as n→∞,
σn(an)
−1aTn ((η̂
or − η0)T, (α̂or −α0)T)T → N(0, 1), (4.7)
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where
σn(an) = σ
[
aTn (U
∗TU∗)−1an
]1/2
.
Moreover, if λ ≫ φn, then there exists a local minimizer (η̂(λ), β̂(λ)) of the objective function
Qn(η,β;λ) given in (3.1) satisfying
P
(
(η̂(λ), β̂(λ)) = (η̂or, β̂
or
)
)
→ 1. (4.8)
Remark 6 By Theorem 3, the local minimizer β̂i(λ) = α̂(λ) = α̂
or for all i with probability
approaching 1. Then, we have for any vectors an1 ∈ IRq with ||an1|| = 1 and an2 ∈ IRp with
||an2|| = 1, as n→∞,
σ−1n1 (an1)a
T
n1(η̂(λ)− η0)→D N(0, 1) and σ−1n2 (an2)aTn2(α̂(λ)−α0)→D N(0, 1),
where
σn1(an1) = σ
[
aTn1[Z
TZ− ZTx(xTx)−1xTZ]−1an1
]1/2
,
σn2(an2) = σ
[
aTn2[x
Tx− xTZ(ZTZ)−1ZTx]−1an2
]1/2
.
5 Testing of a homogeneous model
Next, we propose a residual bootstrapping procedure to test homogeneity of the treatment effects,
i.e., to test whether the model is the homogeneous model, given as yi = z
T
i η+x
T
i α+εi, i = 1, . . . , n.
We consider this model as the reduced model, and the full model is given in (2.2). We estimate
the reduced model by OLS and obtain the resulting estimators as η̂R and α̂R. We then estimate
the full model by our proposed method and denote the resulting estimators as η̂F and β̂
F
i . Let
the fitted values be µ̂Ri = z
T
i η̂
R + xTi α̂
R and µ̂Fi = z
T
i η̂
F + xTi β̂
F
i for the reduced and full models,
respectively. Borrowing the idea from Ha¨rdle and Mammen (1993), we use the integrated squared
deviation between µ̂Ri and µ̂
F
i as the test statistic, which would be Tn =
∑n
i=1(µ̂
F
i − µ̂Ri )2/n. Let
the residuals be ǫ̂i = yi− µ̂Fi for i = 1, . . . , n. We obtain a randomly resampled residual ǫ̂∗i and then
create synthetic response variables y∗i = µ̂
R
i + ǫ̂
∗
i . Using (zi,xi, y
∗
i ) as bootstrap observations, we
obtain the fitted values µ̂∗Ri and µ̂
∗F
i , respectively, by refitting the reduced and full models, and then
creat the bootstrapped version of the test statistic, denoted as T ∗n =
∑n
i=1(µ̂
∗F
i −µ̂∗Ri )2/n. Using the
Monte Carlo simulations to approximate the conditional distribution L∗(T ∗n ) = L(T ∗n|(zi,xi)ni=1),
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we obtain the (1 − α)th quantile t̂α and reject the hypothesis of homogeneity if Tn > t̂α at the
significance level α. Alternatively, we can obtain the P -value pv by finding the (1 − pv)th quantile
t̂pv which satisfies t̂pv = Tn.
6 Numerical studies
6.1 Simulation studies
We use the modified Bayes Information Criterion (BIC) (Wang et al., 2007) for high-dimensional
data settings to select the tuning parameter by minimizing
BIC(λ) = log[
∑n
i=1
(yi − zTi η̂(λ)− xTi β̂i(λ))2/n] + Cn
log n
n
(K̂(λ)p + q), (6.1)
where Cn is a positive number which can depend on n. When Cn = 1, the modified BIC reduces
to the traditional BIC (Schwarz, 1978). Following Lee et al. (2014), we use Cn = log(np + q). We
select λ by minimizing the modified BIC.
One important evaluation criterion for clustering methods is their ability to reconstruct the true
underlying cluster structure. We, therefore, use the Rand Index measure (Rand, 1971) to evaluate
the accuracy of the clustering results. The Rand Index is viewed as a measure of the percentage of
correct decisions made by an algorithm. It is computed by using the formula:
RI =
TP+ TN
TP+ FP + FN + TN
, (6.2)
where a true positive (TP) decision assigns two observations from the same ground truth group
to the same cluster, a true negative (TN) decision assigns two observations from different groups
to different clusters, a false positive (FP) decision assigns two observations from different groups
to the same cluster, and a false negative (FN) decision assigns two observations from the same
group to different clusters. The Rand Index lies between 0 and 1. Higher values of the Rand Index
indicate better performance of the algorithm.
Example 1 (Two subgroups). We simulate data from the heterogeneous model with two groups:
yi = z
T
i η + x
T
i βi + εi, i = 1, . . . , n, with βi = α1wi1 +α2wi2, (6.3)
where zi = (zi1, zi2, zi3)
T ∼ N (0,Σ), in which Σ = {σjj′}, σjj = 1 and σjj′ = 0.3 for j 6= j′, and
xi = (1, xi)
T, in which xi is simulated from centered and standardized binomial with probability 0.7
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for one outcome. We simulate the error terms εi from independent N(0, 0.5
2). Let η = (1, 1, 1)T,
α1 = (2, 2)
T and α2 = (0, 0)
T. Moreover, let wi1 = I(z
2
i1 + ui − 1 < 0) and wi2 = 1 − wi1, where
ui ∼ N (0, 1).
Table 1: The sample mean, median and standard deviation (s.d.) of K̂, the Rand Index (RI) value
and the percentage (per) of K̂ equaling to the true number of subgroups by MCP and SCAD based
on 500 replications with n = 200, 400 in Example 1.
n = 200 n = 400
mean median s.d. RI per mean median s.d. RI per
MCP 2.100 2.000 0.302 0.799 0.890 2.080 2.000 0.272 0.826 0.920
SCAD 2.100 2.000 0.303 0.799 0.890 2.080 2.000 0.273 0.825 0.920
We select the λ value by minimizing the modified BIC given in (6.1). Table 1 reports the sample
mean, median and standard deviation (s.d.) of the estimated number of groups K̂, the average
value of Rand Index (RI) defined in (6.2) for measuring clustering accuracy, and the percentage
(per) of K̂ equaling to the true number of subgroups by the MCP and SCAD methods based on
500 simulation realizations with n = 200, 400. The median of K̂ is 2 which is the true number
of subgroups for all cases. As n increases, the mean gets closer to 2 and the standard deviation
becomes smaller. Moreover, the Rand Index (RI) value and the percentage of correctly selecting
the number of subgroups become closer to 1 as n increases.
To further study the estimation accuracy and evaluate the asymptotic properties stated in
Section 4, Table 2 presents the sample mean, median and asymptotic standard error (ASE) obtained
according to Corollary 1 of the estimators α̂1 = (α̂11, α̂12)
T and α̂2 = (α̂21, α̂22)
T by the MCP and
SCAD methods and oracle estimators α̂or1 = (α̂
or
11, α̂
or
12)
T and α̂or2 = (α̂
or
21, α̂
or
22)
T based on 500
replications with n = 200 and 400. The medians and means of α̂1 and α̂2 are close to the true
values 2 and 0 for all cases. Moreover, the asymptotic standard errors of the penalized estimators
α̂1 and α̂2 are close to those of the oracle estimators α̂
or
1 and α̂
or
2 . This supports the oracle property
established in Theorem 2.
Next, we calculate the mean squared error (MSE) of the estimates η̂ by using the formula
‖η̂−η‖/√q. Figure 2 depicts the boxplots of the MSEs of η̂ by the MCP and SCAD, respectively,
at n = 200 (white) and n = 400 (grey). The MCP and SCAD result in similar MSEs of η̂. The
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Table 2: The sample mean, median and asymptotic standard error (ASE) of the estimators α̂1
and α̂2 by MCP and SCAD and oracle estimators α̂
or
1 and α̂
or
2 based on 500 replications with
n = 200, 400 in Example 1.
n = 200 n = 400
mean median ASE mean median ASE
α̂11 MCP 2.016 2.019 0.046 2.012 2.014 0.034
SCAD 2.016 2.018 0.046 2.012 2.014 0.034
α̂or11 1.996 1.997 0.047 2.009 2.009 0.033
α̂12 MCP 1.927 1.929 0.045 1.947 1.945 0.034
SCAD 1.927 1.929 0.045 1.947 1.946 0.034
α̂or12 1.990 1.989 0.046 1.999 1.999 0.034
α̂21 MCP 0.016 0.016 0.053 0.006 0.010 0.038
SCAD 0.016 0.016 0.053 0.006 0.010 0.038
α̂or21 0.006 0.010 0.055 0.009 0.009 0.039
α̂22 MCP 0.087 0.086 0.054 0.086 0.084 0.038
SCAD 0.087 0.086 0.054 0.086 0.084 0.038
α̂or22 -0.011 -0.014 0.055 0.001 0.001 0.039
MSE values decrease as n increases for both MCP and SCAD.
Lastly, we fit the two-group logistic-normal mixture model given in (2.4) using the R package
“flexmix”, and obtain the average values of RI, which are 0.516 and 0.518, for n = 200 and 400,
respectively, based on 500 simulation realizations. We see that our method leads to higher RI
values than the structured mixture modelling approach, even though our method does not need to
specify the true number of subgroups beforehand. Table 3 reports the sample mean, median and
empirical standard deviation (ESD) of the estimators α̂1 and α̂2 by using the clustering result from
the mixture modelling approach to fit regressions of the two groups. Clearly, the estimated values
from our method given in Table 2 are closer to the true values α1 and α2 than those obtained from
the mixture modelling approach given in Table 3.
Example 2 (Three subgroups). We simulate data from the heterogeneous model with three
groups:
yi = z
T
i η + x
T
i βi+εi, i = 1, . . . , n, with βi = α1wi1 +α2wi2 +α3wi3, (6.4)
where zi, εi and η are simulated in the same way as in Example 1. Let xi = (1, xi)
T, where xi
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Figure 2: The boxplots of the MSEs of η̂ using MCP and SCAD, respectively, with n = 200 (white)
and n = 400 (grey) in Example 1.
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Table 3: The sample mean, median and empirical standard deviation (ESD) of the estimators α̂1
and α̂2 by the mixture modelling approach based on 500 replications in Example 1.
n = 200 n = 400
mean median ESD mean median ESD
α̂11 1.834 1.809 0.266 1.819 1.794 0.179
α̂12 1.254 1.262 0.137 1.263 1.266 0.090
α̂21 0.809 0.842 0.419 0.786 0.796 0.343
α̂22 0.949 0.977 0.210 0.940 0.957 0.151
is generated from centered and standardized binomial with probability 0.5 for one outcome. Let
α1 = (−c,−c)T, α2 = (0, 0)T and α2 = (c, c)T. Moreover, let wi1 = I(|zi1 + zi2 + zi3| < 0.9),
wi2 = I(zi1 + zi2 + zi3 ≥ 0.9) and wi3 = 1− wi1 −wi2. Let n = 200.
Figure 3 displays the fusiongram for (β̂21(λ), . . . , β̂2n(λ)), the elements of the second component
in β̂i(λ)’s, against λ values with c = 2. The fusiongrams for SCAD and MCP look similar. They
generate three subgroups for λ in a certain interval, and the estimates of the treatment effects are
nearly unbiased on this segment. For the LASSO, the estimates merge to a single value quickly
due to the overshrinkage of the L1 penalty.
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Figure 3: Fusiongram for (β̂21(λ), . . . , β̂2n(λ), the second component in β̂i(λ)’s, against λ with
c = 2 in Example 2.
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Table 4: The sample mean, median and standard deviation (s.d.) of K̂, the Rand Index (RI) value
and the percentage (per) of K̂ equaling to the true number of subgroups by MCP and SCAD based
on 500 replications for c = 2, 3 and 4 in Example 2.
c = 2 c = 3 c = 4
MCP SCAD MCP SCAD MCP SCAD
mean 3.450 3.470 3.400 3.410 3.350 3.370
median 3.000 3.000 3.000 3.000 3.000 3.000
s.d. 0.775 0.765 0.769 0.758 0.748 0.726
RI 0.651 0.651 0.658 0.657 0.672 0.672
per 0.630 0.600 0.680 0.660 0.800 0.760
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We next conduct the simulations by selecting λ via minimizing the modified BIC given in (6.1).
Table 4 reports the sample mean, median and standard deviation (s.d.) of the estimated number
of groups K̂, the Rand Index (RI) defined in (6.2) for measuring clustering accuracy, and the
percentage (per) of K̂ equaling to the true number of subgroups by the MCP and SCAD methods
based on 500 simulation realizations for c = 2, 3 and 4. We observe that the median values of K̂ are
3, which is the true number of subgroups, for all cases. Moreover, as the c value becomes larger, the
Rand Index (RI) value and the percentage of correctly selecting the number of subgroups increase.
Example 3 (No treatment heterogeneity). We generate data from a model with homogeneous
treatment effects given by yi = z
T
i η + x
T
i β+εi, i = 1, . . . , n, where zi, xi, εi and η are simulated
in the same way as in Example 1. Set β = (β1, β2)
T = (2, 2) and n = 200. We use our proposed
penalized estimation method to fit the model. The sample mean of the estimated number of groups
K̂ is 1.19 and 1.18, respectively, for the MCP and SCAD methods, and the sample median is 1 for
both methods based on 500 replications.
Table 5: The empirical bias (Bias) for the estimates of β and η, and the average asymptotic
standard error (ASE) calculated according to Corollary 1 and the empirical standard error (ESE)
for the MCP and SCAD methods and oracle estimator (ORACLE) in Example 3.
β1 β2 η1 η2 η3
Bias −0.005 0.003 −0.002 0.007 0.003
MCP ASE 0.035 0.037 0.036 0.037 0.037
ESE 0.034 0.036 0.041 0.038 0.041
Bias −0.004 0.002 −0.001 0.007 0.003
SCAD ASE 0.035 0.036 0.036 0.037 0.037
ESE 0.034 0.036 0.040 0.037 0.041
Bias −0.004 0.002 −0.001 0.006 0.004
ORACLE ASE 0.036 0.036 0.037 0.038 0.038
ESE 0.036 0.037 0.039 0.034 0.039
To evaluate the asymptotic normality established in Corollary 1, Table 5 lists the empirical
bias (Bias) for the estimates of β and η, the average asymptotic standard error (ASE) calculated
according to Corollary 1, the empirical standard error (ESE) for the MCP, SCAD as well as the
oracle estimator (ORACLE). The bias, ASE and ESE for the estimates of β by the MCP and
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SCAD are calculated based on the replications with the estimated number of groups equal to one.
For other cases, they are calculated based on the 500 replications. The biases are small for all
cases. The ESE and ASE are similar for both MCP and SCAD, and they are also close to the
corresponding values for the oracle estimator. These results indicate that the proposed method
works well for the homogeneous model.
6.2 Empirical example
We apply our method to the AIDS Clinical Trials Group Study 175. This study was a randomized
clinical trial to compare zidovudine with other three therapies including zidovudine and didanosine,
zidovudine and zalcitabine, and didanosine in adults infected with the human immunodeficiency
virus type I. We use the log-transformed values of the CD4 counts at 20±5 weeks as the responses
yi (Tsiatis, 2007). For illustration of our method, we use didanosine as the treatment variable and
use a binary variable xi for this treatment. Thus, the coefficient of xi represents the difference in
the treatment effect between the two therapies: didanosine and zidovudine. We randomly select
500 patients from the study to consist of our dataset. Moreover, we include 5 baseline covariates
in the model, which are age (years), weight (kg), Karnofsky score, log-transformed CD8 counts at
baseline, and gender (0 =female, 1 =male).
To see possible heterogeneity in treatment effects, we first fit the homogeneous linear model (2.3)
by using yi as the response and the 5 baseline covariates and the treatment variable as predictors
and obtain the residuals, so that the effects of the baseline covariates are controlled. In Figure 4
(a), it shows the kernel density plot of the residuals. We can see that the distribution has multiple
modes for these patients, which indicates possible heterogeneous treatment effects.
Next, we fit the heterogeneous model yi = z
T
i η+x
T
i βi+εi, i = 1, . . . , n, where βi = (β1i, β2i)
T,
zi = (zi1 . . . , zi5)
T which are the 5 covariates described above, and xi = (1, xi)
T, in which xi is the
binary variable for the treatment didanosine. All of the predictors are centered and standardized
before applying the regularization methods. Figure 5 displays the fusiongrams for the estimated
treatment coefficients, (β̂21(λ), . . . , β̂2n(λ)), by MCP. We obtain similar patterns by using SCAD.
The fusiongrams suggest the existence of heterogeneity in the treatment effects. In particular, the
modified BIC criterion selected the λ value in the region that gives two subgroups with different
treatment effects. Moreover, Figure 4 (b) shows the kernel density plot of the residuals by fitting
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Figure 4: The kernel density plot of the residuals (a) by fitting the homogeneous linear model (2.3)
and (b) by fitting the heterogeneous linear model (2.2).
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the heterogeneous linear model (2.2). It shows a uni-modal distribution.
Let α̂1 = (α̂11, α̂12)
T and α̂2 = (α̂21, α̂22)
T be the estimated coefficients for xi in the two
identified groups Ĝ1 and Ĝ2, respectively, so that β̂i = α̂1 for i ∈ Ĝ1 and β̂i = α̂2 for i ∈ Ĝ2. In
Table 6, we report the estimates (Est.) and their standard errors (s.e.) of α1 = (α11, α12)
T and
α2 = (α21, α22)
T by the MCP and SCAD methods, and those values of β = α1 by the OLS method.
Note that the first and second components represent the coefficients for intercept and the treatment
variable (trt), respectively. We also report the p-values (p-value) for testing whether each coefficient
Figure 5: Fusiongram for β̂2(λ) =β̂21(λ), . . . , β̂2n(λ) against λ .
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Table 6: The estimates (Est.), their standard errors (s.e.) and p-values (P-value) for testing
significance of α1 and α2 by the MCP and SCAD methods, and those values of β = α1 by the
OLS method.
α11(intercept) α12(trt) α21(intercept) α22(trt)
MCP Est. 5.809 -0.065 5.735 1.687
s.e. 0.016 0.041 0.055 0.110
p-value < 0.001 0.112 < 0.001 < 0.001
SCAD Est. 5.809 -0.065 5.737 1.688
s.e. 0.016 0.042 0.055 0.110
p-value < 0.001 0.122 < 0.001 < 0.001
OLS Est. 5.787 0.077 — —
s.e. 0.019 0.040 — —
p-value < 0.001 0.054 — —
is zero or not. By the OLS method, the p-value for testing whether the coefficient of the therapy
(didanosine), α12, is zero or not is greater than 0.05. This result indicates that the effect of the
therapy (didanosine) is not significantly different from that of the standard treatment (zidovudine)
by assuming that the treatment effect is homogeneous. In comparison, by the proposed concave
fusion approach, the p-value for testing significance of the treatment coefficient, α12, for one group
is greater than 0.05, but the p-value for the other group is less than 0.001. This result implies that
although the treatment has no statistically significant effect on one group of patients, its effect on
the other group is prominent.
Next, we employ the bootstrapping method given in Section 5 to test homogeneity of the
treatment effect. We obtain the p-value < 0.01. Thus, the heterogeneity of the treatment effect
is further confirmed by the inference procedure. Lastly, we apply the method to the model (2.2)
with all three therapies by letting xi = (1, xi1, xi2, xi3)
T, where xi1 =zidovudine and didanosine,
xi2 =zidovudine and zalcitabine, and xi3 =didanosine. We obtain two subgroups as well by our
proposed method. However, the numerical results show that the effect of the two combination
therapies xi1 and xi2 is not significantly different from that of the standard treatment (zidovudine)
for both groups. Again the effect of the therapy xi3 (didanosine) is significant in one group, but it
is not significant in the other group.
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7 Discussion
It will be of interest to extend the proposed method to a more general class of regression problems
including generalized linear and Cox regression models. Moreover, it is also possible to relax the
linearity assumption on the covariates zi by considering a nonparametric or semiparametric func-
tional form of zi. For these more complicated models, the ADMM algorithm can still be employed
with some modifications. However, further work is needed to study the theoretical properties. We
refer to Section A.2 for detailed discussions on these extensions. Also, we have assumed that the
number of treatment variables p and the number of confounding variables q are both smaller than
the sample size n, although we allow p and q to diverge with n. For high-dimensional problems with
p > n or q > n, a sparsity condition on the coefficients would be needed to ensure identifiability of
the model. Further studies are needed to develop computational algorithms and theoretical results
for the high-dimensional setting.
Appendix
In the Appendix, we give the computational details, the convergence property of the ADMM
algorithm and the technical proofs for Theorems 1-3.
A.1 Computation
A.1.1 ADMM with concave penalties
We derive an ADMM algorithm for computing the solution (3.2). The key idea is to introduce a
new set of parameters δij = βi−βj . Then, we can reformulate the problem of minimizing (3.1) as
that of minimizing
L0(η,β, δ) =
1
2
∑n
i=1
(yi − zTi η − xTi βi)2 +
∑
i<j
pγ(‖δij‖, λ),
subject to βi − βj − δij = 0, (A.1)
where δ = {δTij, i < j}T. Let 〈a,b〉 = aTb be the inner product of two vectors a and b with the
same dimension. The augmented Lagrangian is
L(η,β, δ,υ) = L0(η,β, δ) +
∑
i<j
〈
υij ,βi − βj − δij
〉
+
ϑ
2
∑
i<j
‖βi − βj − δij‖2, (A.2)
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where the dual variables υ = {υTij, i < j}T are Lagrange multipliers and ϑ is a penalty parameter.
We then compute the estimates of (η,β, δ,υ) through iterations using the ADMM.
For a given value of δm and υm at step m, the iteration goes as follows:
(ηm+1,βm+1) = argmin
η,β
L(η,β, δm,υm), (A.3)
δm+1 = argmin
δ
L(ηm+1,βm+1, δ,υm), (A.4)
υm+1ij = υ
m
ij + ϑ(β
m+1
i − βm+1j − δm+1ij ). (A.5)
In (A.3), the problem is equivalent to the minimization of the function
f(η,β) =
1
2
∑n
i=1
(yi − zTi η − xTi βi)2 +
ϑ
2
∑
i<j
‖βi − βj − δmij + ϑ−1υmij ‖2 + C,
where C is a constant independent of (η,β). Some algebra shows that we can write f(η,β) as
f(η,β) =
1
2
‖Zη +Xβ − y‖2 + ϑ
2
‖Aβ − δm + ϑ−1υm‖2 + C, (A.6)
where A =D ⊗ Ip. Here D = {(ei − ej), i < j}T with ei being the ith unit n × 1 vector whose ith
element is 1 and the remaining ones are 0, Ip is a p × p identity matrix and ⊗ is the Kronecker
product.
Thus for given δm and υm at the mth step, the updates βm+1 and ηm+1 are
βm+1 = (XTQZX+ ϑA
TA)−1[XTQZy + ϑA
T(δm − ϑ−1υm)],
ηm+1 = (ZTZ)−1ZT(y −Xβm+1), (A.7)
where QZ = In − Z(ZTZ)−1ZT. Since
AT(δm − ϑ−1υm) = (DT ⊗ Ip)(δm − ϑ−1υm) = vec((∆m − ϑ−1Υm)D),
where ∆m = {δmij , i < j}p×n(n−1)/2 and Υm = {υmij , i < j}p×n(n−1)/2, then we have
βm+1 = (XTQZX+ ϑA
TA)−1[XTQZy + ϑvec((∆
m − ϑ−1Υm)D)]. (A.8)
In (A.4), after discarding the terms independent of δ, we need to minimize
ϑ
2
‖ζmij − δij‖2 + pγ(‖δij‖, λ) (A.9)
with respect to δij, where ζ
m
ij = β
m
i − βmj + ϑ−1υmij . This is a groupwise thresholding operator
corresponding to pγ .
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For the L1 penalty, the solution is
δm+1ij = S(ζ
m
ij , λ/ϑ), (A.10)
where S(z, t) = (1− t/‖z‖)+z is the groupwise soft thresholding operator. Here (x)+ = x if x > 0
and = 0, otherwise.
For the MCP with γ > 1/ϑ, the solution is
δm+1ij =
{
S(ζmij ,λ/ϑ)
1−1/(γϑ) if ‖ζmij ‖ ≤ γλ,
ζij if ‖ζmij ‖ > γλ.
(A.11)
For the SCAD penalty with γ > 1/ϑ + 1, the solution is
δm+1ij =

S(ζmij , λ/ϑ) if ‖ ζmij‖ ≤ λ+ λ/ϑ,
S(ζmij ,γλ/((γ−1)ϑ))
1−1/((γ−1)ϑ) if λ+ λ/ϑ < ‖ζmij ‖ ≤ γλ,
ζmij if ‖ζmij ‖ > γλ.
(A.12)
Finally, the update of υij is given in (A.5).
We summarize the above analysis in Algorithm 1.
Algorithm 1 ADMM for concave fusion
Require: Initialize δ0, υ0.
1: for m = 0, 1, 2, · · · do
2: Compute βm+1 using (A.8)
3: Compute ηm+1 (A.7)
4: Compute δm+1 (A.10), (A.11) or (A.12)
5: Compute υm+1 using (A.5)
6: if convergence criterion is met, then
7: Stop and denote the last iteration by (η̂(λ), β̂(λ)),
8: else
9: m = m+ 1.
10: end if
11: end for
Ensure: Output
Remark A.1 Our algorithm enables us to have δ̂ij = 0 for a sufficiently large λ. We put observa-
tions i and j in the group with the same treatment effect if δ̂ij = 0. As a result, we have K̂ estimated
groups Ĝ1, . . . , ĜK̂ . The estimated treatment effect for the kth group is α̂k = |Ĝk|−1
∑
i∈Ĝk
β̂i, where
|Ĝk| is the cardinality of Ĝk.
25
Remark A.2 In the algorithm, we require the invertibility of XTQZX+ϑA
TA. It can be derived
that ATA = nInp − (1n ⊗ Ip)(1n ⊗ Ip)T. For any nonzero vector a = (aij , 1 ≤ i ≤ n, 1 ≤ j ≤
p)T ∈ IRnp, we have aT(ϑATA)a ≥ 0 and aT(XTQZX)a ≥ 0. Note that aT(ϑATA)a = 0 if
and only if aij = aj for all i. When aij = aj for all i, we have a
T(XTQZX)a > 0 given that
λmin(
∑n
i=1(x
T
i ,z
T
i )
T(xTi ,z
T
i )) > 0, which is a common assumption that the design matrix needs to
satisfy in linear regression. Therefore, XTQZX+ ϑA
TA is invertible.
Remark A.3 We track the progress of the ADMM based on the primal residual rm+1 = Aβm+1−δm+1.
We stop the algorithm when rm+1 is close to zero such that
∥∥rm+1∥∥ < a for some small value a.
A.1.2 Initial value and computation of the solution path
To start the ADMM algorithm described above, it is important to find a reasonable initial value.
For this purpose, we consider the ridge fusion criterion given by
LR(η,β) =
1
2
‖Zη +Xβ − y‖2 + λ
∗
2
∑
1≤i<j≤n
‖βi − βj‖2,
where λ∗ is the tuning parameter having a small value. We use λ∗ = 0.001 in our analysis. Then
LR(η,β) can be written as
LR(η,β) =
1
2
‖Zη +Xβ − y‖2 + λ
∗
2
‖Aβ‖2,
where A is defined in (A.6). The solutions are
βR(λ
∗) = (βTR,1(λ
∗), . . . ,βTR,n(λ
∗))T = (XTQZX+ λ
∗ATA)−1XTQZy,
ηR(λ
∗) = (ZTZ)−1ZT(y −XβR(λ∗)),
where QZ is given in (A.8). Next, we assign the subjects to K
∗ groups by ranking the median
values of βTR,i(λ
∗). We let K∗ =
⌊
n1/2
⌋
to ensure that it is sufficiently large, where ⌊a⌋ denotes the
largest integer no greater than a. We then find the initial estimates η0 and β0 from least squares
regression with K∗ groups. Let the initial estimates δ0ij = β
0
i − β0j and υ0 = 0.
To compute the solution path of η and β along the λ values, we use the warm start and
continuation strategy to update the solutions. Let [λmin, λmax] be the interval on which we compute
the solution path, where 0 ≤ λmin < λmax < ∞. Let λmin = λ0 < λ1 < · · · < λK ≡ λmax be a
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grid of λ values in [λmin, λmax]. Compute (η̂(λ0), β̂(λ0)) using (η
0,β0) as the initial value. Then
compute (η̂(λk), β̂(λk)) using (η̂(λk−1), β̂(λk−1)) as the initial value for each k = 1, . . . ,K.
Note that we start from the smallest λ value in computing the solution path. This is different
from the coordinate descent algorithms for computing the solution path in penalized regression
problems (Friedman et al., 2007), where the algorithms start at the λ value that forces all the
coefficients to zero.
A.1.3 Convergence of the algorithm
We next derive the convergence properties of the ADMM algorithm.
Proposition A.1 Let rm = Aβm−δm and sm+1 = ϑAT(δm+1 − δm) be the primal residual and
the dual residual in the ADMM described above, respectively. It holds that limm→∞ ‖rm‖2 = 0 and
limm→∞ ‖sm‖2 = 0 for the MCP and SCAD penalties.
This proposition shows that the primal feasibility and the dual feasibility are achieved by the
algorithm.
Proof. By the definition of δm+1, we have
L(ηm+1,βm+1, δm+1,υm)≤L(ηm+1,βm+1, δ,υm)
for any δ. Define
fm+1 = inf
Aβm+1−δ=0
{1
2
∥∥y − Zηm+1−Xβm+1∥∥2 +∑
i<j
pγ(|δij|, λ)}
= inf
Aβm+1−δ=0
L(ηm+1,βm+1, δ,υm).
Then
L(ηm+1,βm+1, δm+1,υm)≤fm+1.
Let t be an integer. Since υm+1 = υm + ϑ(Aβm+1−δm+1), then we have
υm+t−1 = υm + ϑ
∑t−1
i=1
(Aβm+i−δm+i),
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and thus
L(ηm+t,βm+t, δm+t,υm+t−1)
=
1
2
∥∥y − Zηm+t−Xβm+t∥∥2 + (υm+t−1)T(Aβm+t−δm+t)
+
ϑ
2
‖Aβm+t−δm+t‖2 +
∑
i<j
pγ(|δm+tij |, λ)
=
1
2
∥∥y − Zηm+t−Xβm+t∥∥2 + (υm)T(Aβm+t−δm+t)
+ϑ
∑t−1
i=1
(Aβm+i−δm+i)T(Aβm+t−δm+t)
+
ϑ
2
‖Aβm+t−δm+t‖2 + pγ(|δm+tij |, λ)
≤ fm+t.
Since the objective function L(η,β, δ,υ) is differentiable with respect to (η,β) and is convex with
respect to δ, by applying the results in Theorem 4.1 of (Tseng, 2001), the sequence (ηm,βm, δm)
has a limit point, denoted by (η∗,β∗,δ∗). Then we have
f∗ = lim
m→∞
fm+1 = lim
m→∞
fm+t = inf
Aβ∗−δ=0
{1
2
‖y − Zη∗−Xβ∗‖2 +
∑
i<j
pγ(|δij|, λ)},
and for all t ≥ 0
lim
m→∞
L(µm+t,βm+t,ηm+t,υm+t−1)
=
1
2
‖y − Zη∗−Xβ∗‖2 +
∑
i<j
pγ(|δ∗ij |, λ) + limm→∞(υ
m)T(Aβ∗−δ∗) + (t− 1
2
)ϑ‖Aβ∗−δ∗‖2
≤ f∗.
Hence limm→∞ ‖rm‖2 = r∗=‖Aβ∗−δ∗‖2 = 0.
Since βm+1 minimizes L(ηm,β, δm,υm) by definition, we have that
L(ηm,β, δm,υm)/∂β = 0,
and moreover,
L(ηm,βm+1, δm,υm)/∂β
= XT(Zηm+Xβm+1−y) +ATυm + ϑAT(Aβm+1−δm)
= XT(Zηm+Xβm+1−y) +AT(υm + ϑ(Aβm+1−δm))
= XT(Zηm+Xβm+1−y) +AT(υm+1 − ϑ(Aβm+1−δm+1) + ϑ(Aβm+1−δm))
= XT(Zηm+Xβm+1−y) +ATυm+1 + ϑAT(δm+1 − δm).
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Therefore,
sm+1 = ϑAT(δm+1 − δm) = −(XT(Zηm+Xβm+1−y) +ATυm+1).
Since ‖Aβ∗−δ∗‖2 = 0,
lim
m→∞
L(ηm,βm+1, δm,υm)/∂β
= lim
m→∞
XT(Zηm+Xβm+1−y) +ATυm+1
= XT(Zη∗ +Xβ∗ − y) +ATυ∗ = 0.
Therefore, limm→∞ s
m+1 = 0.
A.2 Extension to nonlinear models
In this paper, we focus on the linear regression model (2.2) to introduce our proposed method for
exploring treatment heterogeneity. It is worth mentioning that our method can be readily extended
to semi-parametric models by relaxing the linearity assumption on zi. Considering the model:
yi = m(zi) + x
T
i βi + εi, i = 1, . . . , n,
where m(·) is an unknown function of zi. This model has no constraint on the functional form of
zi. Following the approach in Ma et al. (2015), we can estimate m(·) by tensor-product regression
splines weighted by categorical kernel functions, where the splines are used for the continuous pre-
dictors and the categorical kernels are for the discrete predictors, respectively. Then the objective
function for obtaining the estimates consists of two parts similar as given in (3.1). The first part is a
weighted least squares criterion as presented in equation (2) of Ma et al. (2015), and the second part
contains the same penalty functions as given in (3.1). As a result, the proposed ADMM algorithm
proposed in Section A.1 can be applied. Moreover, we can also assume semi-parametric structures
on m(·) for further dimensionality reduction while retaining model flexibility. For example, when
zi is a set of continuous variables, we can assume the additive structure:
m(zi) = m1(zi1) + · · ·+mq(ziq),
where mk(·) for k = 1, ..., q are unknown functions. Also the partially linear additive structure is
another popular semi-parametric model, given as
m(zi) = m1(zi1) + · · · +mq1(ziq1) + zTi2η,
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where zi = (z
T
i1,z
T
i2)
T, zi1 = (zi1, ..., ziq1)
T and zi2 = (zi,q1+1, ..., ziq)
T. If we use regression splines
to approximate the unknown functions, the same ADMM algorithm given in Section A.1 can be
applied to obtain the parameter estimators with the components in zi replaced by their spline
basis functions. We refer to Ma et al. (2013) for the details of using regression splines to estimate
unknown functions in these settings.
It is also of interest to extend the proposed method to the case with discrete responses. For a
general scenario, one may fit a generalized linear model:
E(yi|zi,xi) = µi = g−1(zTi η + xTi βi), i = 1, . . . , n,
where g is a known monotone link function. For obtaining the estimates of the parameters, we can
consider the negative quasi-likelihood function
Q(µ, y) =
∫ y
µ
{(y − ξ)/V (ξ)}dξ,
where V (·) is the conditional variance of y given (z,x). Then the parameter estimates can be
obtained by minimizing
∑n
i=1
Q(g−1(zTi η + x
T
i βi), yi) +
∑
1≤i<j≤n
p(‖βi − βj‖, λ).
Because Q(g−1(zTi η + x
T
i βi), yi) is differentiable with respect to (η, βi), the ADMM algorithm
given in Section A.1 can be straightforwardly applied.
A.3 Proof of Theorem 1
In this section we show the results in Theorem 1. For every β ∈MG , it can be written as β =Wα.
Recall U = (Z,XW). We have(
η̂or
α̂or
)
= arg min
η∈Rq ,α∈RKp
1
2
‖y − Zη −Xβ‖ = arg min
η∈Rq ,α∈RKp
1
2
‖y − Zη −XWα‖2.
Thus (
η̂or
α̂or
)
= [(Z,XW)T(Z,XW)]−1(Z,XW)Ty = (UTU)−1UTy.
Then (
η̂or − η0
α̂or −α0
)
= (UTU)−1UTε.
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Hence ∥∥∥∥∥
(
η̂or − η0
α̂or −α0
)∥∥∥∥∥ ≤ ∥∥(UTU)−1∥∥ ∥∥UTε∥∥ . (A.13)
By Condition (C1), we have ∥∥(UTU)−1∥∥ ≤ C−11 |Gmin|−1 . (A.14)
Moreover
P (
∥∥UTε∥∥
∞
> C
√
n log n) ≤ P (∥∥ZTε∥∥
∞
> C
√
n log n) + P (
∥∥∥(XW)Tε∥∥∥
∞
> C
√
n log n),
for some constant 0 < C <∞. Since XW = [xTi 1{i ∈ Gk}]n,Ki=1,k=1, we have∥∥∥(XW)Tε∥∥∥
∞
= sup
j,k
|
∑n
i=1
xijεi1{i ∈ Gk}|
and by union bound, Condition (C1) that
∑n
i=1 x
2
ij1{i ∈ Gk } = |Gk| and Condition (C3),
P
(∥∥∥(XW)Tε∥∥∥
∞
> C
√
n log n
)
≤
∑p,K
j=1,k=1
P
(
|
∑n
i=1
xijεi1{i ∈ Gk}| > C
√
n log n
)
≤
∑p,K
j=1,k=1
P
(
|
∑n
i=1
xijεi1{i ∈ Gk}| >
√
|Gk|C
√
log n
)
≤ 2Kp exp(−c1C2 log n) = 2Kpn−c1C2 .
By union bound, Condition (C1) that ‖Zk‖ =
√
n, where Zk is the kth column of Z, and Condition
(C3),
P
(∥∥ZTε∥∥
∞
> C
√
n log n
)
≤
∑q
k=1
P
(
|ZTk ε| >
√
nC
√
log n
)
≤ 2q exp(−c1C2 log n) = 2qn−c1C2 .
It follows that
P (
∥∥UTε∥∥
∞
> C
√
n log n) ≤ 2(Kp + q)n−c1C2 .
Since
∥∥UTε∥∥ ≤ √q +Kp ∥∥UTε∥∥
∞
, then
P (
∥∥UTε∥∥ > C√q +Kp√n log n) ≤ 2(Kp+ q)n−c1C2 . (A.15)
Therefore, by (A.13), (A.14) and (A.15), we have with probability at least 1− 2(Kp+ q)n−c1C2 ,∥∥∥∥∥
(
η̂or − η0
α̂or −α0
)∥∥∥∥∥ ≤ CC−11 √q +Kp |Gmin|−1√n log n.
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The result (4.2) in Theorem 1 is proved by letting C = c
−1/2
1 . Moreover,∥∥∥β̂or − β0∥∥∥2 = ∑K
k=1
∑
i∈Gk
∥∥α̂ork −α0k∥∥2 ≤ |Gmax|∑Kk=1 ∥∥α̂ork −α0k∥∥2
= |Gmax|
∥∥α̂or −α0∥∥2 ≤ |Gmax|φ2n,
and
sup
i
∥∥∥β̂ori − β0i ∥∥∥ = sup
k
∥∥α̂ork −α0k∥∥ ≤ ‖α̂or −α0‖ ≤ φn.
Let U = (U1, . . . ,Un)
T, and Ξn = U
TU. Then
aTn ((η̂
or − η0)T, (α̂or −α0)T)T =
∑n
i=1
aTnΞ
−1
n Uiεi.
Hence
E{aTn ((η̂or − η0)T, (α̂or −α0)T)T} = 0,
and for any vector an ∈ IRq+Kp with ||an|| = 1,
var{aTn ((η̂or − η0)T, (α̂or −α0)T)T}
= σ2n(an) = σ
2
[
aTn (U
TU)−1an
] ≥ σ2aTnΞ−1n an.
Moreover, for any ǫ > 0,∑n
i=1
E[(aTnΞ
−1
n Uiεi)
2 · 1{|aTnΞ−1n Uiεi|>ǫσn(an)}]
≤
∑n
i=1
{E(aTnΞ−1n Uiεi)4}1/2[P{|aTnΞ−1n Uiεi| > ǫσn(an)}]1/2.
Since E(ε4i ) ≤ c for some constant c ∈ (0,∞) by Condition (C2), then∑n
i=1
{E(aTnΞ−1n Uiεi)4}1/2 ≤ c1/2aTnΞ−1n an.
Moreover,
max
i
P
{|aTnΞ−1n Uiεi| > ǫσn(an)}
≤ max
i
E(aTnΞ
−1
n Uiεi)
2/{ǫ2σ2n(an)} ≤ c′ǫ−2(q +Kp)aTnΞ−1n Ξ−1n an/(aTnΞ−1n an)
for some constant c′ ∈ (0,∞). Therefore, by the above results, we have
σ−2n (an)
∑n
i=1
E[(aTnΞ
−1
n Uiεi)
2 · 1{|aTnΞ−1n Uiεi|>ǫσn(an)}]
≤ {σ2aTnΞ−1n an}−1c1/2aTnΞ−1n an{c′ǫ−2(q +Kp)aTnΞ−1n Ξ−1n an/(aTnΞ−1n an)}1/2
≤ c1/2c′1/2C−1/21 ǫ−1σ−1(q +Kp)1/2 |Gmin|−1/2 = o(1).
Then, the result (4.4) follows from Lindeberg–Feller Central Limit Theorem.
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A.4 Proof of Theorem 2
In this section we show the results in Theorem 2. Define
Ln(η,β) =
1
2
‖y − Zη −Xβ‖2, Pn(β) = λ
∑
i<j
ρ(‖βi − βj‖),
LGn(η,α) =
1
2
‖y − Zη −XWα‖2, P Gn (α) = λ
∑
k<k′
|Gk‖Gk′ |ρ(‖αk −αk′‖),
and let
Qn(η,β) = Ln(η,β) + Pn(β), Q
G
n(η,α) = L
G
n(η,α) + P
G
n (α).
Let T : MG → RKp be the mapping that T (β) is the Kp × 1 vector consisting of K vectors
with dimension p and its kth vector component equals to the common value of βi for i ∈ Gk. Let
T ∗ : Rnp → RKp be the mapping that T ∗(β) = {|Gk|−1
∑
i∈Gk
βTi , k = 1, . . . ,K}T. Clearly, when
β ∈MG , T (β) =T ∗(β).
By calculation, for every β ∈MG , we have Pn(β) = P Gn (T (β)) and for every α ∈ RK , we have
Pn(T
−1(α)) = P Gn (α). Hence
Qn(η,β) = Q
G
n(η,T (β)), Q
G
n(η,α) = Qn(η,T
−1(α)). (A.16)
Consider the neighborhood of (η0,β0):
Θ= {η ∈Rq,β∈RKp:∥∥η − η0∥∥ ≤ φn, sup
i
∥∥βi − β0i ∥∥ ≤ φn}.
By Theorem 1, there exists an event E1 in which
∥∥η̂or − η0∥∥ ≤ φn, sup
i
∥∥∥β̂ori − β0i∥∥∥ ≤ φn
and P (EC1 ) ≤ 2(q +Kp)n−1. Hence (η̂or, β̂
or
) ∈ Θ in E1. For any β ∈Rnp, let β∗ = T−1(T ∗(β)).
We show that (η̂or, β̂
or
) is a strictly local minimizer of the objective function (3.1) with probability
approaching 1 through the following two steps.
(i). In the event E1, Qn(η,β
∗) > Qn(η̂
or,β̂
or
) for any (ηT,βT)T ∈ Θ and ((η)T, (β∗)T)T 6=
((η̂or)T, (β̂
or
)T)T.
(ii). There is an event E2 such that P (E
C
2 ) ≤ 2n−1. In E1 ∩ E2, there is a neighborhood of
((η̂or)T, (β̂
or
)T)T, denoted by Θn such that Qn(η,β) ≥ Qn(η,β∗) for any ((η)T, (β∗)T)T ∈ Θn ∩Θ
for sufficiently large n.
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Therefore, by the results in (i) and (ii), we have Qn(η,β) > Qn(η̂
or,β̂
or
) for any (ηT,βT)T ∈
Θn ∩Θ and ((η)T, (β)T)T 6= ((η̂or)T, (β̂or)T)T in E1∩E2, so that ((η̂or)T, (β̂or)T)T is a strict local
minimizer of Qn(η,β) (3.1) over the event E1 ∩ E2 with P (E1 ∩ E2) ≥ 1 − 2(q +Kp + 1)n−1 for
sufficiently large n.
In the following we prove the result in (i). We first show P Gn (T
∗(β)) = Cn for any β ∈Θ, where
Cn is a constant which does not depend on β. Let T
∗(β) = α = (αT1 , . . . ,α
T
K)
T. It suffices to show
that ‖αk − αk′‖ > aλ for all k and k′. Then by Condition (C2), ρ(‖αk − αk′‖) is a constant, and
as a result P Gn (T
∗(β)) is a constant. Since
‖αk −αk′‖ ≥ ‖α0k −α0k′‖ − 2 sup
k
‖αk −α0k ‖,
and
sup
k
‖αk −α0k ‖2 = sup
k
∥∥∥|Gk|−1∑
i∈Gk
βi −α0k
∥∥∥2 = sup
k
∥∥∥|Gk|−1∑
i∈Gk
(βi − β0i )
∥∥∥2
= sup
k
|Gk|−2
∥∥∥∑
i∈Gk
(βi − β0i )
∥∥∥2 ≤ sup
k
|Gk|−1
∑
i∈Gk
∥∥(βi − β0i )∥∥2
≤ sup
i
∥∥βi − β0i ∥∥2 ≤ φ2n, (A.17)
then for all k and k′
‖αk −αk′‖ ≥ ‖α0k −α0k′‖ − 2 sup
k
‖αk −α0k ‖ ≥ bn − 2φn > aλ,
where the last inequality follows from the assumption that bn > aλ ≫ φn. Therefore, we have
P Gn (T
∗(β)) = Cn, and hence Q
G
n(η,T
∗(β)) = LGn(η,T
∗(β)) + Cn for all (η
T,βT)T ∈ Θ. Since
((η̂or)T, (α̂or)T)T is the unique global minimizer of LGn(η,α), then L
G
n(η,T
∗(β)) > LGn(η̂
or,α̂or) for
all (ηT, (T ∗(β))T)T 6= ((η̂or)T, (α̂or)T)T and hence QGn(η,T ∗(β)) > QGn(η̂or,α̂or) for all T ∗(β) 6=α̂or.
By (A.16), we haveQGn(η̂
or, α̂or) = Qn(η̂
or,β̂
or
) andQGn(η,T
∗(β)) = Qn(η, T
−1(T ∗(β))) = Qn(η, β
∗).
Therefore, Qn(η, β
∗) > Qn(η̂
or,β̂
or
) for all β∗ 6=β̂or, and the result in (i) is proved.
Next we prove the result in (ii). For a positive sequence tn, let Θn = {βi: supi ‖βi−β̂
or
i ‖ ≤ tn}.
For (ηT,βT)T ∈ Θn ∩Θ, by Taylor’s expansion, we have
Qn(η,β)−Qn(η,β∗) = Γ1 + Γ2,
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where
Γ1 = −(y − Zη −Xβm)TX(β − β∗)
Γ2 =
n∑
i=1
∂Pn(β
m)
∂βTi
(βi − β∗i ).
and βm = αβ + (1− α)β∗ for some constant α ∈ (0, 1). Moreover,
Γ2 = λ
∑
{j>i}
ρ′(‖βmi − βmj ‖)‖βmi − βmj ‖−1(βmi − βmj )T(βi − β∗i )
+λ
∑
{j<i}
ρ′(‖βmi − βmj ‖)‖βmi − βmj ‖−1(βmi − βmj )T(βi − β∗i )
= λ
∑
{j>i}
ρ′(‖βmi − βmj ‖)‖βmi − βmj ‖−1(βmi − βmj )T(βi − β∗i )
+λ
∑
{i<j}
ρ′(‖βmj − βmi ‖)‖βmj − βmi ‖−1(βmj − βmi )T(βj − β∗j )
= λ
∑
{j>i}
ρ′(‖βmi − βmj ‖)‖βmi − βmj ‖−1(βmi − βmj )T{(βi − β∗i )− (βj − β∗j)}.(A.18)
When i, j ∈ Gk, β∗i = β∗j , and βmi − βmj = α(βi − βj). Thus,
Γ2 = λ
K∑
k=1
∑
{i,j∈Gk,i<j}
ρ′(‖βmi − βmj ‖)‖βmi − βmj ‖−1(βmi − βmj )T(βi − βj)
+λ
∑
k<k′
∑
{i∈Gk,j′∈Gk′}
ρ′(‖βmi − βmj ‖)‖βmi − βmj ‖−1(βmi − βmj )T{(βi − β∗i )− (βj − β∗j)}.
Moreover,
sup
i
‖β∗i−β0i ‖2 = sup
k
‖αk −α0k ‖2 ≤ φ2n, (A.19)
where the last inequality follows from (A.17). Since βmi is between βi and β
∗
i ,
sup
i
‖βmi −β0i ‖ ≤ α sup
i
‖βi−β0i ‖+ (1− α) sup
i
‖β∗i−β0i ‖ ≤ αφn + (1− α)φn = φn. (A.20)
Hence for k 6= k′, i ∈ Gk, j′ ∈ Gk′ ,
‖βmi − βmj ‖ ≥ min
i∈Gk,j′∈Gk′
‖β0i − β0j‖ − 2max
i
‖βmi − β0i ‖ ≥ bn − 2φn > aλ,
and thus ρ′(‖βmi − βmj ‖) = 0. Therefore,
Γ2 = λ
K∑
k=1
∑
{i,j∈Gk,i<j}
ρ′(‖βmi − βmj ‖)‖βmi − βmj ‖−1(βmi − βmj )T(βi − βj)
= λ
K∑
k=1
∑
{i,j∈Gk,i<j}
ρ′(‖βmi − βmj ‖)‖βi − βj‖,
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where the last step follows from βmi − βmj = α(βi − βj). Furthermore, by the same reasoning as
(A.17), we have
sup
i
‖β∗i−β̂
or
i ‖ = sup
k
‖αk−α̂ork ‖2 ≤ sup
i
‖β−β̂ori ‖.
Then
sup
i
‖βmi − βmj ‖ ≤ 2 sup
i
‖βmi − β∗i ‖ ≤ 2 sup
i
‖βi − β∗i ‖
≤ 2(sup
i
‖βi − β̂
or
i ‖+ sup
i
‖β∗i − β̂
or
i ‖) ≤ 4 sup
i
‖βi − β̂
or
i ‖ ≤ 4tn.
Hence ρ′(‖βmi − βmj ‖) ≥ ρ′(4tn) by concavity of ρ(·). As a result,
Γ2 ≥
∑K
k=1
∑
{i,j∈Gk,i<j}
λρ′(4tn)‖βi − βj‖. (A.21)
Let
Q = (QT1 , . . . ,Q
T
n )
T = [(y − Zη −Xβm)TX]T.
Then
Γ1 = −QT(β − β∗) = −
∑K
k=1
∑
{i,j∈Gk}
QTi (βi − βj)
|Gk|
= −
∑K
k=1
∑
{i,j∈Gk}
QTi (βi − βj)
2|Gk| −
∑K
k=1
∑
{i,j∈Gk}
QTi (βi − βj)
2|Gk|
= −
∑K
k=1
∑
{i,j∈Gk}
(Qj −Qi)T(βj − βi)
2|Gk|
= −
∑K
k=1
∑
{i,j∈Gk,i<j}
(Qj −Qi)T(βj − βi)
|Gk| . (A.22)
Moreover,
Qi = (yi − zTi η − xTi βmi )xi = (εi + zTi (η0 − η) + xTi (β0i − βmi ))xi,
and then
sup
i
‖Qi‖ ≤ sup
i
{‖xi‖(‖ε‖∞ + ‖zi‖‖η0 − η‖+‖xi‖‖β0i − βmi ‖)}
By Condition (C1) that supi ‖xi‖ ≤ C2
√
p and supi ‖zi‖ ≤ C3
√
q, (A.20) that supi ‖β0i −βmi ‖ ≤ φn
and ‖η0 − η‖ ≤ φn, we have
sup
i
‖Qi‖ ≤ C2√p(‖ε‖∞ + C3√qφn + C2√pφn).
By Condition (C3)
P (‖ε‖∞ >
√
2c−11
√
log n) ≤
∑n
i=1
P (|εi| >
√
2c−11
√
log n) ≤ 2n−1.
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Thus there is an event E2 such that P (E
C
2 ) ≤ 2n−1, and over the event E2,
sup
i
‖Qi‖ ≤ C2√p(
√
2c−11
√
log n+ C3
√
qφn + C2
√
pφn).
Then
|(Qj −Qi)
T(βj − βi)
|Gk| |
≤ |Gmin|−1‖Qj −Qi‖‖βi − βj‖ ≤ |Gmin|−12 sup
i
‖Qi‖‖βi − βj‖
≤ 2C2|Gmin|−1√p(
√
2c−11
√
log n+ C3
√
qφn + C2
√
pφn)‖βi − βj‖. (A.23)
Therefore, by (A.21), (A.22) and (A.23), we have
Qn(η,β)−Qn(η,β∗)
≥
K∑
k=1
∑
{i,j∈Gk,i<j}
{λρ′(4tn)− 2C2|Gmin|−1√p(
√
2c−11
√
log n+ C3
√
qφn + C2
√
pφn)}‖βi − βj‖.
Let tn = o(1), then ρ
′(4tn) → 1. Since λ ≫ φn, p = o(n), and |Gmin|−1p = o(1), then λ ≫
|Gmin|−1√p
√
log n, λ ≫ |Gmin|−1√pq and λ ≫ |Gmin|−1pφn. Therefore, Qn(η,β) − Qn(η,β∗) ≥ 0
for sufficiently large n, so that the result in (ii) is proved.
A.5 Proof of Theorem 3
In this section we show the results in Theorem 3. The proofs of (4.6) and (4.7) follow the same
arguments as the proof of Theorem 1 by letting X˜ = x and |Gmin| = n, and thus they are omitted.
Next, we will show (4.8). It follows similar procedures as the proof of Theorem 2 with the details
given below. Define M = {β ∈ IRnp : β1 = · · · = βn}. For each β ∈ M, we have βi = α for all i.
Let T :M→ Rp be the mapping that T (β) is the p× 1 vector equal to the common vector α. Let
T ∗ : Rnp → Rp be the mapping that T ∗(β) = {n−1∑ni=1 βi. Clearly, when β ∈M, T (β) =T ∗(β).
Consider the neighborhood of (η0,β0):
Θ= {η∈Rq,β∈Rp: ∥∥η − η0∥∥ ≤ φn, sup
i
∥∥βi − β0i∥∥ ≤ φn},
where φn = c
−1/2
1 C
−1
1
√
q + p
√
n−1 log n. By the result in (4.6), there exists an event E1 such that
on the event E1, ∥∥η̂or − η0∥∥ ≤ φn, sup
i
∥∥∥β̂ori − β0i ∥∥∥ ≤ φn,
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and P (EC1 ) ≤ 2(q + p)n−1. Hence (η̂or, β̂
or
) ∈ Θ on the event E1. For any β∈Rnp, let β∗ =
T−1(T ∗(β)). We show that (η̂or, β̂
or
) is a strictly local minimizer of the objective function (3.1)
with probability approaching 1 through the following two steps.
(i). On the event E1, Qn(η,β
∗) > Qn(η̂
or,β̂
or
) for any (ηT,βT)T ∈ Θ and ((η)T, (β∗)T)T 6=
((η̂or)T, (β̂
or
)T)T.
(ii). There is an event E2 such that P (E
C
2 ) ≤ 2n−1. On E1 ∩ E2, there is a neighborhood of
((η̂or)T, (β̂
or
)T)T, denoted by Θn such that Qn(η,β) ≥ Qn(η,β∗) for any ((η)T, (β∗)T)T ∈ Θn ∩Θ
for sufficiently large n.
Therefore, by the results in (i) and (ii), we have Qn(η,β) > Qn(η̂
or,β̂
or
) for any (ηT,βT)T ∈
Θn ∩ Θ and ((η)T, (β)T)T 6= ((η̂or)T, (β̂or)T)T in E1 ∩ E2, so that ((η̂or)T, (β̂or)T)T is a strict
local minimizer of Qn(η,β) (3.1) on the event E1 ∩E2 with P (E1 ∩E2) ≥ 1− 2(q + p+ 1)n−1 for
sufficiently large n.
By the definition of ((η̂or)T, (β̂
or
)T)T, we have 12‖y − Zη − Xβ∗‖2 > 12‖y − Zη̂or − Xβ̂
or‖2
for any ((η)T, (β)T)T ∈ Θ and ((η)T, (β∗)T)T 6= ((η̂or)T, (β̂or)T)T. Moreover, since pγ(‖β̂ori −
β̂
or
j ‖, λ) = pγ(‖β∗i − β∗j‖, λ) = 0 for 1 ≤ i, j ≤ n, we have Qn(η,β∗) = 12‖y − Zη − Xβ∗‖2 and
Qn(η̂
or,β̂
or
) = 12‖y − Zη̂or −Xβ̂
or‖2. Therefore, Qn(η,β∗) > Qn(η̂or,β̂or).
Next we prove the result in (ii). For a positive sequence tn, let Θn = {βi: supi ‖βi−β̂
or
i ‖ ≤ tn}.
For (ηT,βT)T ∈ Θn ∩Θ, by Taylor’s expansion, we have
Qn(η,β)−Qn(η,β∗) = Γ1 + Γ2,
where
Γ1 = −(y − Zη −Xβm)TX(β − β∗)
Γ2 =
n∑
i=1
∂Pn(β
m)
∂βTi
(βi − β∗i ).
Pn(β) = λ
∑
i<j ρ(‖βi − βj‖), and βm = aβ + (1 − a)β∗ for some constant a ∈ (0, 1). Moreover,
by (A.18),
Γ2 = λ
∑
{j>i}
ρ′(‖βmi − βmj ‖)‖βmi − βmj ‖−1(βmi − βmj )T{(βi − β∗i )− (βj − β∗j )}
= λ
∑
{j>i}
ρ′(‖βmi − βmj ‖)‖βi − βj‖,
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where the second equality holds due to the fact that β∗i = β
∗
j and β
m
i − βmj = a(βi − βj). Let
T ∗(β) = α. Then, following the same argument as (A.19), we have
sup
i
‖β∗i−β0i ‖2 = ‖α−α0‖2 ≤ sup
i
‖βi−β0i ‖2.
Then
sup
i
‖βmi − βmj ‖ ≤ 2 sup
i
‖βmi − β∗i ‖ ≤ 2 sup
i
‖βi − β∗i ‖
≤ 2(sup
i
‖βi − β̂
or
i ‖+ sup
i
‖β∗i − β̂
or
i ‖) ≤ 4 sup
i
‖βi − β̂
or
i ‖ ≤ 4tn.
Hence ρ′(‖βmi − βmj ‖) ≥ ρ′(4tn) by concavity of ρ(·). As a result,
Γ2 ≥
∑
{i<j}
λρ′(4tn)‖βi − βj‖. (A.24)
Let
Q = (QT1 , . . . ,Q
T
n )
T = [(y − Zη −Xβm)TX]T.
By the same reasoning as the proof for (A.22), we have
Γ1 = −QT(β − β∗) = −n−1
∑
{i<j}
(Qj −Qi)T(βj − βi). (A.25)
By the same argument as the proof for (A.23), we have that there is an event E2 such that
P (EC2 ) ≤ 2n−1, and on the event E2,
n−1|(Qj −Qi)T(βj − βi)|
≤ 2C2n−1√p(
√
2c−11
√
log n+ C3
√
qφn + C2
√
pφn)‖βi − βj‖. (A.26)
Therefore, by (A.24), (A.25) and (A.26), we have
Qn(η,β)−Qn(η,β∗)
≥
∑
{i<j}
{λρ′(4tn)− 2C2n−1√p(
√
2c−11
√
log n+ C3
√
qφn + C2
√
pφn)}‖βi − βj‖.
Let tn = o(1), then ρ
′(4tn)→ 1. Since λ≫ φn, p = o(n), and n−1p = o(1), then λ≫ n−1√p
√
log n,
λ ≫ n−1√pq and λ ≫ n−1pφn. Therefore, Qn(η,β) − Qn(η,β∗) ≥ 0 for sufficiently large n, so
that the result in (ii) is proved.
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